for Veterans and the Public
Rescriptor (delavirdine)
- Type of Drug: Nonnucleoside Reverse Transcriptase Inhibitor
- Nonnucleoside reverse transcriptase inhibitors prevent HIV from using an enzyme called reverse transcriptase to make copies of itself. These drugs are also known as NNRTIs, nonnucleosides or "nonnukes."
Approved adult dosing
four 100 mg tablets Rescriptor three times a day
Morning
Rescriptor 100 mg
Mid-day
Rescriptor 100 mg
Evening
Rescriptor 100 mg
two 200 mg tablets Rescriptor three times a day
Morning
Rescriptor 200 mg
Mid-day
Rescriptor 200 mg
Evening
Rescriptor 200 mg
Notes on taking this medication
- No food restrictions, can take with or without food
- Rescriptor interacts with many other drugs; persons using Rescriptor with those drugs may need an adjustment to their dose of Rescriptor or the other drugs; consult your medical provider
Side effects
- Rash (usually occurs within first 3 weeks of starting drug)
- Liver inflammation and increased liver enzyme levels
- Headache; fatigue; stomach upset
See accompanying chart: Tips for Common Side Effects
My doctor's instructions
Disclaimer: This information is not meant to substitute for advice from your medical provider or pharmacist. If you have any questions about your medication dosing, talk to your medical provider or pharmacist.
Search this website
Share this pageContents
Scroll over drug name to see other names for the drug.
